BF Biosciences in talks to manufacture COVID-19 drug in Pakistan

0
2

Remdesivir appears to help treat those suffering from COVID-19, the disease caused by the novel coronavirus. Photo: AFP KARACHI: Ferozsons Laboratories have announced that its listed subsidiary BF Biosciences Limited (BFBL) has been negotiating for a non-exclusive license agreement with Gilead Sciences to manufacture and sell remdesivir to supply in Pakistan and 126 other countries, reported The News.

NO COMMENTS